Atlas Trials

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Clinical trial NCT00189839 · COMPLETED

Trial details

NCT number
NCT00189839
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney Transplantation
Start date
2004-08-01
Primary completion
2006-12-01
Enrollment
699

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.